Clinical Trial Update: Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis B [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of Pegasys for chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Chronic Hepatitis B | Phase 3 | Status: COMPLETED